Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire Steven Cohen’s Top High Dividend Stock Picks and Ones He Bets Against

Page 1 of 2

Investment professionals usually recommend a balanced portfolio of stocks and bonds, something like 60% stocks and 40% bonds. They also recommend that investors should increase their bond allocations as they get older. This is usually a sound idea, but we aren’t living in usual times anymore. Central banks have been artificially reducing the yields on both short-term and long-term bonds. The 30-year US Treasury bonds yield 2.55% and that’s before inflation. Inflation usually runs between 2% to 3% annually, which means long-term bond investors are getting real returns of close to zero. Long-term bond yields may decline in the short-term and bond investors may enjoy strong short-term capital gains, but we don’t think bonds are good long-term capital allocation alternatives for investors near their retirement ages looking to grow their nest eggs.


We think dividend stocks are better alternatives than bonds as they will more likely be able to increase their payouts over the next 30 years. An investor who buys shares of a dividend stock that yields 4% today will probably enjoy much higher payoff in average annual returns over the next 30 years, whereas the average annual return of the 30-year Treasury bond will be 2.55% over the next 30 years.

In this article we will focus on the top three high dividend picks of billionaire Steve Cohen of Point72 Asset Management. These are Royal Dutch Shell plc (ADR) (NYSE:RDS.A), Noble Corp plc (NYSE:NE), and AstraZeneca plc (ADR) (NYSE:AZN), as of the end of 2014. You probably know that hedge funds usually don’t invest in dividend stocks solely for their yields. They think these stocks are undervalued and will probably deliver strong capital gains over the next few years. By investing in these companies, you can get a steady cash flow from a dividend yield of at least 4% and can still profit from the long-term growth of your capital.

Dividend payments are one of the bonuses inherent in investing long-term in many large-cap companies, though these companies are otherwise unlikely to generate the same kind of returns for investors as small-cap companies can. This is exemplified by our research into the returns of hedge funds’ top small-cap picks compared to their top large-cap picks. The top small-cap picks greatly outperformed their larger peers and the broader market, returning 132% in forward testing from the end of August 2012 through March 11, 2015, compared to returns of 52.6% generated by the S&P 500 (SPY) during the same period (read more details here).

Cohen’s top high dividend pick is Royal Dutch Shell plc (ADR) (NYSE:RDS.A), which currently sports an annual dividend yield of 6.21% based on a $0.94 quarterly payout to shareholders of record, which it has maintained for the past four quarters. Royal Dutch Shell plc (ADR) (NYSE:RDS.A)’s yield has steadily improved over the past few years as its dividend payments have increased by more than 10% since early 2012, while shares of the giant oil and gas company have actually decreased by more than 15% over the same period. Cohen made a huge move into Royal Dutch Shell plc (ADR) (NYSE:RDS.A) during the fourth quarter, increasing his position to 1.52 million shares valued at $101.95 million from only 12,000 held previously. That elevated him to being the fourth-largest shareholder among the funds we track, with Pzena Investment Management and Highfields Capital Management also owning substantial positions.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!